Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan

被引：0

作者：

Chen-Hua Liu

Po-Yueh Chen

Jyh-Jou Chen

Ching-Chu Lo

Wei-Wen Su

Kuo-Chih Tseng

Chun-Jen Liu

Chia-Sheng Huang

Ke-Jhang Huang

Sheng-Shun Yang

Cheng-Yuan Peng

Ming-Chang Tsai

Wei-Yu Kao

Chi-Yang Chang

Yu-Lueng Shih

Yu-Jen Fang

Chi-Yi Chen

Pei-Lun Lee

Jow-Jyh Huang

Pei-Yuan Su

Chi-Wei Tseng

Chien-Ching Hung

Chung-Hsin Chang

Yi-Jie Huang

Hsueh-Chou Lai

Chun-Chao Chang

Fu-Jen Lee

Tsai‐Yuan Hsieh

Jia-Horng Kao

机构：

[1] National Taiwan University Hospital,Department of Internal Medicine

[2] National Taiwan University Hospital,Hepatitis Research Center

[3] National Taiwan University Hospital,Department of Internal Medicine

[4] Ditmanson Medical Foundation Chiayi Christian Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[5] Chi-Mei Medical Center,Division of Gastroenterology and Hepatology

[6] St. Martin De Porres Hospital,Department of Internal Medicine

[7] Changhua Christian Hospital,Division of Gastroenterology, Department of Internal Medicine

[8] Dalin Tzu Chi Hospital,Department of Internal Medicine

[9] Tzuchi University,School of Medicine

[10] Yang Ming Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[11] China Medical University Beigang Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[12] Taichung Veterans General Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[13] Chung Shan Medical University,School of Medicine

[14] National Chung Hsing University,Institute of Biomedical Sciences

[15] China Medical University Hospital,Center for Digestive Medicine, Department of Internal Medicine

[16] China Medical University,School of Medicine

[17] Chung Shan Medical University Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[18] Taipei Medical University Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[19] Taipei Medical University,Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine

[20] Taipei Medical University,Graduate Institute of Clinical Medicine, College of Medicine

[21] Fu Jen Catholic University Hospital,Division of Gastroenterology and Hepatology, Department of Internal Medicine

[22] National Defense Medical Center,Division of Gastroenterology, Department of Internal Medicine, Tri

[23] National Taiwan University College of Medicine,Service General Hospital

[24] National Taiwan University College of Medicine,Department of Tropical Medicine and Parasitology

来源：

Hepatology International | 2021年 / 15卷

关键词：

Hepatitis C virus; Direct acting antiviral; Sofosbuvir; Velpatasvir; Sustained virologic response; Adverse event; East Asian; Effectiveness; Safety; Pangenotypic;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：338 / 349

页数：11

共 50 条

[1] Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
Liu, Chen-Hua
Chen, Po-Yueh
Chen, Jyh-Jou
Lo, Ching-Chu
Su, Wei-Wen
Tseng, Kuo-Chih
Liu, Chun-Jen
Huang, Chia-Sheng
Huang, Ke-Jhang
Yang, Sheng-Shun
Peng, Cheng-Yuan
Tsai, Ming-Chang
Kao, Wei-Yu
Chang, Chi-Yang
Shih, Yu-Lueng
Fang, Yu-Jen
Chen, Chi-Yi
Lee, Pei-Lun
Huang, Jow-Jyh
Su, Pei-Yuan
Tseng, Chi-Wei
Hung, Chien-Ching
Chang, Chung-Hsin
Huang, Yi-Jie
Lai, Hsueh-Chou
Chang, Chun-Chao
Lee, Fu-Jen
Hsieh, Tsai-Yuan
Kao, Jia-Horng
HEPATOLOGY INTERNATIONAL, 2021, 15 (02) : 338 - 349
[2] Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
Pin-Nan Cheng
Lein-Ray Mo
Chun-Ting Chen
Chi-Yi Chen
Chung-Feng Huang
Hsing-Tao Kuo
Ching-Chu Lo
Kuo-Chih Tseng
Yi-Hsiang Huang
Chi-Ming Tai
Cheng-Yuan Peng
Ming-Jong Bair
Chien-Hung Chen
Ming-Lun Yeh
Chih-Lang Lin
Chun-Yen Lin
Pei-Lun Lee
Lee-Won Chong
Chao-Hung Hung
Te Sheng Chang
Jee-Fu Huang
Chi-Chieh Yang
Jui-Ting Hu
Chih-Wen Lin
Chia-Chi Wang
Wei-Wen Su
Tsai-Yuan Hsieh
Chih-Lin Lin
Wei-Lun Tsai
Tzong-Hsi Lee
Guei-Ying Chen
Szu-Jen Wang
Chun-Chao Chang
Sheng-Shun Yang
Wen-Chih Wu
Chia-Sheng Huang
Kwok-Hsiung Chou
Chien-Neng Kao
Pei-Chien Tsai
Chen-Hua Liu
Mei-Hsuan Lee
Chien-Yu Cheng
Ming-Chang Tsai
Chun-Jen Liu
Chia-Yen Dai
Han-Chieh Lin
Jia-Horng Kao
Wan-Long Chuang
Ming-Lung Yu
Infectious Diseases and Therapy, 2022, 11 : 485 - 500
[3] Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
Cheng, Pin-Nan
Mo, Lein-Ray
Chen, Chun-Ting
Chen, Chi-Yi
Huang, Chung-Feng
Kuo, Hsing-Tao
Lo, Ching-Chu
Tseng, Kuo-Chih
Huang, Yi-Hsiang
Tai, Chi-Ming
Peng, Cheng-Yuan
Bair, Ming-Jong
Chen, Chien-Hung
Yeh, Ming-Lun
Lin, Chih-Lang
Lin, Chun-Yen
Lee, Pei-Lun
Chong, Lee-Won
Hung, Chao-Hung
Chang, Te Sheng
Huang, Jee-Fu
Yang, Chi-Chieh
Hu, Jui-Ting
Lin, Chih-Wen
Wang, Chia-Chi
Su, Wei-Wen
Hsieh, Tsai-Yuan
Lin, Chih-Lin
Tsai, Wei-Lun
Lee, Tzong-Hsi
Chen, Guei-Ying
Wang, Szu-Jen
Chang, Chun-Chao
Yang, Sheng-Shun
Wu, Wen-Chih
Huang, Chia-Sheng
Chou, Kwok-Hsiung
Kao, Chien-Neng
Tsai, Pei-Chien
Liu, Chen-Hua
Lee, Mei-Hsuan
Cheng, Chien-Yu
Tsai, Ming-Chang
Liu, Chun-Jen
Dai, Chia-Yen
Lin, Han-Chieh
Kao, Jia-Horng
Chuang, Wan-Long
Yu, Ming-Lung
INFECTIOUS DISEASES AND THERAPY, 2022, 11 (01) : 485 - 500
[4] EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR IN TREATING HEPATITIS C VIRUS INFECTION IN A REAL-WORLD SETTING
Wilton, James
Wong, Stanley
Yu, Amanda
Cook, Darrel
Butt, Zahid Ahmad
Alvarez, Maria Jose
Binka, Mawuena
Darvishian, Maryam
Yoshida, Eric M.
Ramji, Alnoor
Krajden, Mel
Janjua, Naveed
HEPATOLOGY, 2019, 70 : 983A - 983A
[5] REAL-WORLD EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR/VOXILAPREVIR AS A HEPATITIS C VIRUS INFECTION SALVAGE TREATMENT
Krajden, Mel
Cook, Darrel
Wong, Stanley
Wilton, James
Butt, Zahid Ahmad
Bartlett, Sofia
Pearce, Margo
Ramji, Alnoor
Yoshida, Eric M.
Yu, Amanda
Alvarez, Maria Jose
Binka, Mawuena
Janjua, Naveed
HEPATOLOGY, 2019, 70 : 914A - 914A
[6] Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment
Janjua, Naveed
Wilton, James
Cook, Darrel
Wong, Stanley
Butt, Zahid
Bartlett, Sofia
Pearce, Margo
Ramji, Alnoor
Yoshida, Eric
Yu, Amanda
Alvarez, Maria
Binka, Mawuena
Krajden, Mel
JOURNAL OF HEPATOLOGY, 2020, 73 : S356 - S357
[7] SOFOSBUVIR/VELPATASVIR WITH OR WITHOUT RIBAVIRIN FOR CHRONIC HEPATITIS C VIRUS INFECTED PATIENTS WITH LIVER CIRRHOSIS AND CHRONIC KIDNEY DISEASE: REAL-WORLD EXPERIENCE FROM SOUTHWEST CHINA
Rui, Yang Yong
Huang, Kang
Zhao, Zhirong
Bai, Jinsong
Wu, Lei
Li, Junyi
Li, Shenghao
Li, Liu
Li, Haiwen
Du, Yingrong
HEPATOLOGY, 2023, 78 : S741 - S741
[8] Sofosbuvir/Velpatasvir for Chronic Hepatitis C Infection in Patients
Sharara, Ala
Rustom, Luma Basma O.
Marrache, Majd
Rimmani, Hussein
Koussa, Suzanne
Taher, Ali
HEPATOLOGY, 2018, 68 : 396A - 396A
[9] Real-world effectiveness of sofosbuvir/velpatasvir for the treatment of hepatitis C virus in prison settings
Rosati, Silvia
Wong, Alexander
Di Marco, Vito
Perez-Hernandez, Paco
Macedo, Guilherme
Brixko, Christian
Ranieri, Roberto
Campanale, Francesca
Bascia, Annalisa
Fernandez-Rodriguez, Conrado
de Ledinghen, Victor
Maida, Ivana
Teti, Elisabetta
Mangia, Alessandra
Vanstraelen, Kim
Hernandez, Candido
Mertens, Michael
Ntalla, Ioanna
Ramroth, Heribert
Jimenez, Elena
FUTURE VIROLOGY, 2022, 17 (07) : 419 - 428
[10] Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan
Yu-Ting Huang
Yung-Yu Hsieh
Wei-Ming Chen
Shui-Yi Tung
Kuo-Liang Wei
Chen-Heng Shen
Kao-Chi Chang
Chung-Kuang Lu
Chih-Wei Yen
Sheng-Nan Lu
Chao-Hung Hung
Te-Sheng Chang
BMC Gastroenterology, 21

← 1 2 3 4 5 →